Calypte developing urine-based home HIV test service.
This article was originally published in The Tan Sheet
Executive Summary
CALYPTE DEVELOPING URINE-BASED HOME HIV TEST SERVICE, the company said in a registration statement for its initial public offering. The firm plans to use approximately $4 mil. of net proceeds from the offering to establish a reference laboratory where consumers will mail urine samples for testing, the company stated. The move represents part of a broader effort at Calypte to develop a home HIV test service.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning